Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2013
11/20/2013CN102875459B Synthetic method of 6-acetyl-2-pyridine formic ester
11/20/2013CN102311298B Method for preparing chlorinated aromatic hydrocarbon through chlorination of bromine on aromatic ring
11/20/2013CN102245573B Heteroaryl derivatives as cftr modulators
11/20/2013CN102171189B Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
11/20/2013CN101913973B Preparation and use of alkylating agents
11/19/2013US8586762 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
11/19/2013US8586756 Process for the preparation of 2,2-difluoroethylamine derivatives starting from N-(2,2-difluoroethyl)prop-2-en-1-amine
11/19/2013US8586607 Compounds for the treatment of metabolic diseases
11/19/2013US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/19/2013US8586570 Sox-based kinase sensor
11/19/2013US8586536 Neprilysin inhibitors
11/19/2013US8585930 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors
11/19/2013CA2746307C Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
11/19/2013CA2618340C Piperidine and piperazine derivatives as p2x3 antagonists
11/19/2013CA2603030C Benzyloxypropylamine derivative
11/19/2013CA2539403C 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
11/14/2013WO2013170165A1 Antibacterial agents
11/14/2013WO2013167991A1 Compositions and methods for the treatment of metabolic disorders
11/14/2013WO2013167633A1 Acrylamide compounds for combating invertebrate pests
11/14/2013WO2013166966A1 Polymorphs of flourine-containing deuterium-substituted omega-diphenylurea or salts thereof
11/14/2013WO2013166621A1 1-(dihydronaphthalenyl)pyridones as melanin-concentrating hormone receptor 1 antagonists
11/14/2013US20130303775 Process for production of aromatic alcohol or heterocyclic aromatic alcohol
11/14/2013US20130303774 Method For Producing Beta-Fluoroalcohol
11/14/2013US20130303576 Enzyme inhibitors
11/14/2013US20130303572 Novel inhibitors of matrix metalloproteinases
11/14/2013US20130303568 Substituted 2-Aminoacetamides and the Use Thereof
11/14/2013US20130303549 Novel biaromatic compounds that modulate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/14/2013US20130303548 Indication for use of niacin (nicotinic acid) for treatment, prevention and reversal of fatty liver disease
11/14/2013US20130303526 Pyridine Compounds and the Uses Thereof
11/14/2013US20130303507 Substituted hetero-biaryl compounds and their uses
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/13/2013EP2662353A2 Antibacterial agents
11/13/2013EP2569263B1 A thionation process and a thionating agent
11/13/2013CN103391923A Benzamide derivatives as p2x7 receptor antagonists
11/13/2013CN103391922A Compound containing substituted o-terphenyl structure, and organic electroluminescent element
11/13/2013CN103387567A NEPT compound and preparation method and application thereof
11/13/2013CN103387536A Polymorphs of fluorine-containing deuterium-substituted omega-diphenylcarbamide or polymorphs of salts of fluorine-containing deuterium-substituted omega-diphenylcarbamide
11/13/2013CN103387535A Substituted alkynylpyridine compound, and application method and use thereof
11/13/2013CN103387534A Method for separating tropicamide raceme
11/13/2013CN102267940B Synthesis of triamine containing symmetrical triaryl pyridine structure and hyperbranched polyimide thereof
11/13/2013CN102105448B Phenoxypyridinylamide derivatives and use thereof in the treatment of PDE4 mediated disease states
11/13/2013CN101939299B Inhibitors for brassinosteroid signalling
11/13/2013CN101786975B Lipoamide series derivates, preparation method and pharmaceutical application thereof
11/13/2013CA2833209A1 Trpv1 antagonists and uses thereof
11/12/2013US8580967 Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate and processes for the preparation thereof
11/12/2013US8580962 Spiroheterocyclic compounds as mGlu5 antagonists
11/12/2013US8580826 Hydroxybenzoate salts of metanicotine compounds
11/12/2013CA2565184C Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/07/2013WO2013165575A1 Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives
11/07/2013WO2013072938A3 Process for the preparation of roflumilast
11/07/2013US20130296573 System for Controlling the Reactivity of Boronic Acids
11/07/2013US20130296380 Novel Ureas for the Treatment and Prevention of Cancer
11/07/2013US20130296369 Cyanoenamines and their use as fungicides
11/07/2013US20130296346 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
11/07/2013US20130296309 Aryl pyridine as aldosterone synthase inhibitors
11/07/2013US20130296276 Heterocyclic ring compound
11/07/2013US20130295051 Novel compounds and compositions for the inhibition of nampt
11/07/2013US20130295040 Polymer
11/06/2013EP2660239A1 Chemical compounds as synthetic intermediates
11/06/2013CN103384654A Radiofluorination method
11/06/2013CN103382177A Roflumilast N-oxide polymorphs and their preparation methods and pharmaceutical composition
11/06/2013CN103382176A Novel vanilloid receptor ligands and their use for producing medicaments
11/06/2013CN103382162A Preparation method of acylazido compound
11/06/2013CN103382144A Alkyl aromatic alpha- halogenation method
11/06/2013CN102225919B Curcumin analogue and preparation method thereof as well as application thereof in preparation of Alzheimer disease resisting medicament
11/06/2013CN102174014B Preparation method of 3-chloropyridine
11/06/2013CN102167683B Bivalent cation magnetic ionic liquids and preparation method thereof
11/06/2013CN102099336B Novel phenylamino isonicotinamide compounds
11/06/2013CN102050747B Preparation method of organic onium tetrafluoroaluminate and method for preparing aluminum oxide through low temperature electrolysis
11/06/2013CN101935285B Hexafluoroaluminate of organic onium, and preparation method and application thereof
11/06/2013CN101657423B Iminipyridine derivatives and their uses as microbiocides
11/06/2013CN101611005B Substituted acetophenones useful as PDE4 inhibitors
11/06/2013CN101522624B Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
11/05/2013US8575353 Compounds for the treatment of addiction
11/05/2013US8575346 Ruthenium based complexes
11/05/2013US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013US8575202 Chelator stabilized cationic ammonium compounds and compositions comprising the same
11/05/2013CA2672722C Methods of preparing substituted tetracyclines with transition metal-based chemistries
11/05/2013CA2594345C Compositions and methods of treating cell proliferation disorders
11/05/2013CA2491994C Modulators of the glucocorticoid receptor
10/2013
10/31/2013WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same
10/31/2013WO2013161851A1 Benzamide derivative
10/31/2013WO2013161308A1 Amide derivatives as ttx-s blockers
10/31/2013WO2013160419A1 Novel compounds
10/31/2013US20130289282 Thin film tube reactor
10/31/2013US20130289270 Amination of Aryl Alcohol Derivatives
10/31/2013US20130289117 Hydroxyl compounds and compositions for cholesterol management and related uses
10/31/2013US20130289081 Derivatives of nicotinic acid n-oxide, their preparation and their use as inhibitors of enzyme 3-hydroxyanthranilate-3, 4-dioxygenase
10/31/2013US20130289076 Cyclopropylamine inhibitors of oxidases
10/31/2013US20130289034 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
10/31/2013US20130289010 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors
10/31/2013US20130288886 Ionic fluids
10/30/2013EP2657225A2 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
10/30/2013EP2657222A1 Beta-aminocarbonyl compound production method
10/30/2013EP2657214A1 Process for production of aromatic alcohol or heterocyclic aromatic alcohol
10/30/2013EP2655331A1 Glucagon receptor modulators
10/30/2013EP2655330A1 Substituted pyridines as sodium channel blockers
10/30/2013EP2655329A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid
10/30/2013EP2655328A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)- pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid
10/30/2013CN103380117A Picolinamide inhibitors of kinases
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 633